Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.

Leijon H, Kaprio T, Heiskanen A, Satomaa T, Hiltunen JO, Miettinen MM, Arola J, Haglund C.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):3990-4000. doi: 10.1210/jc.2017-00401.

PMID:
28938401
2.

Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.

Ekholm FS, Pynnönen H, Vilkman A, Pitkänen V, Helin J, Saarinen J, Satomaa T.

ChemMedChem. 2016 Nov 21;11(22):2501-2505. doi: 10.1002/cmdc.201600372. Epub 2016 Oct 27.

PMID:
27786414
3.

Synthesis of the copper chelator TGTA and evaluation of its ability to protect biomolecules from copper induced degradation during copper catalyzed azide-alkyne bioconjugation reactions.

Ekholm FS, Pynnönen H, Vilkman A, Koponen J, Helin J, Satomaa T.

Org Biomol Chem. 2016 Jan 21;14(3):849-52. doi: 10.1039/c5ob02133b. Epub 2015 Dec 8.

PMID:
26647226
4.

N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.

Kaprio T, Satomaa T, Heiskanen A, Hokke CH, Deelder AM, Mustonen H, Hagström J, Carpen O, Saarinen J, Haglund C.

Mol Cell Proteomics. 2015 Feb;14(2):277-88. doi: 10.1074/mcp.M114.041632. Epub 2014 Dec 1.

5.

Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell marker.

Hirvonen T, Suila H, Tiitinen S, Natunen S, Laukkanen ML, Kotovuori A, Reinman M, Satomaa T, Alfthan K, Laitinen S, Takkinen K, Räbinä J, Valmu L.

Biores Open Access. 2013 Oct;2(5):336-45. doi: 10.1089/biores.2013.0026.

6.

Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.

Nystedt J, Anderson H, Tikkanen J, Pietilä M, Hirvonen T, Takalo R, Heiskanen A, Satomaa T, Natunen S, Lehtonen S, Hakkarainen T, Korhonen M, Laitinen S, Valmu L, Lehenkari P.

Stem Cells. 2013 Feb;31(2):317-26. doi: 10.1002/stem.1271.

7.

Lectin from Erythrina cristagalli supports undifferentiated growth and differentiation of human pluripotent stem cells.

Mikkola M, Toivonen S, Tamminen K, Alfthan K, Tuuri T, Satomaa T, Natunen J, Saarinen J, Tiittanen M, Lampinen M, Valmu L, Partanen J, Otonkoski T.

Stem Cells Dev. 2013 Mar 1;22(5):707-16. doi: 10.1089/scd.2012.0365. Epub 2012 Dec 21.

PMID:
23106381
8.

The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells.

Hirvonen T, Suila H, Kotovuori A, Ritamo I, Heiskanen A, Sistonen P, Anderson H, Satomaa T, Saarinen J, Tiitinen S, Räbinä J, Laitinen S, Natunen S, Valmu L.

Stem Cells Dev. 2012 Feb 10;21(3):455-64. doi: 10.1089/scd.2011.0405. Epub 2011 Nov 2.

PMID:
21933024
9.

The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope.

Natunen S, Satomaa T, Pitkänen V, Salo H, Mikkola M, Natunen J, Otonkoski T, Valmu L.

Glycobiology. 2011 Sep;21(9):1125-30. doi: 10.1093/glycob/cwq209. Epub 2010 Dec 15.

10.

Are globoseries glycosphingolipids SSEA-3 and -4 markers for stem cells derived from human umbilical cord blood?

Suila H, Pitkänen V, Hirvonen T, Heiskanen A, Anderson H, Laitinen A, Natunen S, Miller-Podraza H, Satomaa T, Natunen J, Laitinen S, Valmu L.

J Mol Cell Biol. 2011 Apr;3(2):99-107. doi: 10.1093/jmcb/mjq041. Epub 2010 Dec 12.

PMID:
21149348
11.

Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms.

Nystedt J, Anderson H, Hirvonen T, Impola U, Jaatinen T, Heiskanen A, Blomqvist M, Satomaa T, Natunen J, Saarinen J, Lehenkari P, Valmu L, Laine J.

Stem Cells. 2010 Feb;28(2):258-67. doi: 10.1002/stem.250.

12.

Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.

Satomaa T, Heiskanen A, Leonardsson I, Angström J, Olonen A, Blomqvist M, Salovuori N, Haglund C, Teneberg S, Natunen J, Carpén O, Saarinen J.

Cancer Res. 2009 Jul 15;69(14):5811-9. doi: 10.1158/0008-5472.CAN-08-0289. Epub 2009 Jul 7.

13.

The N-glycome of human embryonic stem cells.

Satomaa T, Heiskanen A, Mikkola M, Olsson C, Blomqvist M, Tiittanen M, Jaatinen T, Aitio O, Olonen A, Helin J, Hiltunen J, Natunen J, Tuuri T, Otonkoski T, Saarinen J, Laine J.

BMC Cell Biol. 2009 Jun 2;10:42. doi: 10.1186/1471-2121-10-42.

14.

Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage.

Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, Laitinen A, Tiitinen S, Natunen S, Aitio O, Miller-Podraza H, Wuhrer M, Deelder AM, Natunen J, Laine J, Lehenkari P, Saarinen J, Satomaa T, Valmu L.

Glycoconj J. 2009 Apr;26(3):367-84. doi: 10.1007/s10719-008-9217-6. Epub 2008 Nov 27.

PMID:
19037724
15.

N-glycan structures and associated gene expression reflect the characteristic N-glycosylation pattern of human hematopoietic stem and progenitor cells.

Hemmoranta H, Satomaa T, Blomqvist M, Heiskanen A, Aitio O, Saarinen J, Natunen J, Partanen J, Laine J, Jaatinen T.

Exp Hematol. 2007 Aug;35(8):1279-92.

PMID:
17662891
16.

N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.

Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U, Mikkola M, Olsson C, Miller-Podraza H, Blomqvist M, Olonen A, Salo H, Lehenkari P, Tuuri T, Otonkoski T, Natunen J, Saarinen J, Laine J.

Stem Cells. 2007 Jan;25(1):197-202. Epub 2006 Sep 28.

17.

O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition.

Satomaa T, Renkonen O, Helin J, Kirveskari J, Mäkitie A, Renkonen R.

Blood. 2002 Apr 1;99(7):2609-11.

Supplemental Content

Loading ...
Support Center